After a rapid growth period through the mid-2000s, the global cord blood banking market reached saturation and stabilized through approximately 2012. Since that time, the market has been aggressively consolidating.
In this article:
Your Global Leader in Stem Cell Market Research
After a rapid growth period through the mid-2000s, the global cord blood banking market reached saturation and stabilized through approximately 2012. Since that time, the market has been aggressively consolidating.
In this article:
This is an interview with Kyle Cetrulo, Founder and CEO of AuxoCell Laboratories, a company specializing in solid tissue processing using its AC:Px System. In addition to heading Auxocell and being a thought-leader on perinatal stem cells, Kyle is an organizer for the upcoming 2nd Annual Perinatal Stem Cell Society Conference that will take place each March in Aspen, CO.
[Read more…]
Cord blood banking initially emerged as a commercial service in the late 1980’s and early 1990’s, because of potential applications related to Transplant Medicine. While an effective therapeutic approach, this unfortunately produced low utilization rates for stored cord blood units.
As a result, Regenerative Medicine (RM) applications of cord blood emerged over time, expanding approved used for cord blood to approximately 80 total. Exciting regenerative medicine applications for umbilical cord blood include its potential to treat neurological conditions, such as cerebral palsy (CP) and autism. These applications are being researched by one of the luminaries in the field, Dr. Joanne Kurtzberg of the Duke Center for Autism and Brain Development and the Carolinas Cord Blood Bank.
As the cord blood market has expanded to include a wide range of perinatal tissues, including umbilical cord tissue, placental blood and tissue, and amniotic fluid and tissue, the new frontier has become Longevity applications. Perinatal is a term describing the period right before and after birth. [Read more…]
Cord blood conferences have been expanding in number and frequency over the past decade. Cord blood banking is the long-term storage and preservation of umbilical cord blood collected during the birth of a newborn. It is collected, because it is rich in hematopoietic stem cells (HSCs), a stem cell type that is widely used in transplant medicine and can be used to treat over 80 different conditions. The matrix of the umbilical cord, called Wharton’s Jelly, is also a rich source of mesenchymal stem cells (MSCs), a cell type that is now being explored in more than 800 clinical trials worldwide.
Each year, cord blood industry experts gather at these events to discuss trends, research progress, and clinical and technological advances.
Below, we highlight leading cord blood industry events, many of which BioInformant attends, sponsors, or helps to organize. [Read more…]
Amniotic stem cells, which can be sourced from the amniotic fluid or the placenta after a live, healthy birth, possess a unique blend of multipotency and lack of tumorigenicity. In an extension of the cord blood banking model, these cells may improve outcomes where long-term cell survival and functionality is important. Recently, I had the honor of interview Dr. Todd McAllister, Executive Director at the Amnion Foundation, a non-profit organization with the mission to build a genetically diverse public cell bank that can provide an immunological match to the majority of the population.
In this interview, we discuss the Amnion Foundation’s vision, research and clinical approach, scale-out strategy, and interest in joint partnerships that will support greater utilization of amniotic stem cells. It is captivating to get an insider look at the Amnion Foundation, a non-profit that is introducing a new extension to the traditional cord blood and tissue banking market.
As the cord blood banking market matures and consolidates and diversifies into new types of perinatal stem cell storage, the Amnion Foundation will be uniquely positioned to advise cord blood banks on how to integrate amniotic stem cell banking into their service portfolio.